DC ChemicalsChemicals for Life Science
sales@dcchemicals.com

DCL0013 · Updated 24 October 2026

iL-19
Literature records

Search the tables and observations reproduced from the product literature guide. Rows may represent measurements, recipes or experimental context; they are not all independent experiments.

Table 1

Component: iL-19 | Company product: DCL0013 | mol%: 50 | Molecular weight (g/mol): 1040.70

Table 1

Component: DSPC | Company product: DC57005 | mol%: 10 | Molecular weight (g/mol): 790.15

Table 1

Component: Cholesterol | Company product: DCD-041 | mol%: 38.5 | Molecular weight (g/mol): 386.65

Table 1

Component: DMG-PEG2000 | Company product: DC40169 | mol%: 1.5 | Molecular weight (g/mol): 2507

Table 2

Parameter: Organic stocks | Literature information: iL-19 25 mg/mL; cholesterol 20 mg/mL; DSPC 20 mg/mL; DMG-PEG2000 10 mg/mL, all in anhydrous ethanol

Table 2

Parameter: Aqueous phase | Literature information: circLuc in 10 mM sodium citrate, pH 5.0; citrate buffer contains 20% (w/v) sucrose

Table 2

Parameter: Mixing | Literature information: Rapid pipette mixing; reported organic:aqueous volume ratio 1:3

Table 2

Parameter: Mixing equipment / flow | Literature information: No microfluidic flow rate reported; do not substitute a microfluidic protocol as the published method

Table 2

Parameter: IM preparation | Literature information: Diluted with PBS, pH 7.4, to 66.5 µL; 33 µL per quadriceps reported

Table 2

Parameter: IV preparation | Literature information: Diluted with PBS, pH 7.4, to 100 µL; preliminary retro-orbital administration

Table 2

Parameter: Post-processing | Literature information: No dialysis, ethanol-removal or sterile-filtration step specified in the supplied protocol

Table 2

Parameter: Formulated-LNP storage study | Literature information: 4 °C for 14 days; monitored size, PDI and zeta potential. This is not a validated shelf life for the supplied neat lipid.

Table 3

Condition: Standard iL-19, 30:1 mass ratio | Relative expression vs standard iL-19: 100%

Table 3

Condition: DOPE replacing DSPC | Relative expression vs standard iL-19: 92%

Table 3

Condition: β-Sitosterol replacing cholesterol | Relative expression vs standard iL-19: 63%

Table 3

Condition: Fucosterol replacing cholesterol | Relative expression vs standard iL-19: 71%

Table 3

Condition: Mass ratio 10:1 / 20:1 / 40:1 | Relative expression vs standard iL-19: 67% / 90% / 96%

Table 3

Condition: Mass ratio 50:1 / 60:1 / 70:1 / 80:1 / 90:1 / 100:1 | Relative expression vs standard iL-19: 83% / 71% / 56% / 57% / 52% / 63%

Table 4

Cargo: circLuc | Size (nm): 128 ± 3 | PDI: 0.11 ± 0.02 | Zeta (mV): 28.1 ± 2.1 | Apparent pKa: 6.7 ± 0.09 | EE (%): 92 ± 0.5

Table 4

Cargo: Linear mFluc | Size (nm): 150 ± 5 | PDI: 0.15 ± 0.03 | Zeta (mV): 11.6 ± 0.9 | Apparent pKa: 6.8 ± 0.03 | EE (%): 87 ± 0.2

Table 5

Lipid: SM-102 | Relative expression (SM-102 = 100%): 100

Table 5

Lipid: iL-15 | Relative expression (SM-102 = 100%): 1032

Table 5

Lipid: iL-16 | Relative expression (SM-102 = 100%): 1323

Table 5

Lipid: iL-17 | Relative expression (SM-102 = 100%): 1441

Table 5

Lipid: iL-18 | Relative expression (SM-102 = 100%): 1665

Table 5

Lipid: iL-19 | Relative expression (SM-102 = 100%): 2800

Table 5

Lipid: iL-20 | Relative expression (SM-102 = 100%): 2890

Open the complete guide for source context →